SCHEMBL19904479

SCHEMBL19904479

CCc1cc(CCCN2CCCCC2)ccc1OC1CC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 6/20 0.45
SIGMAR1 Q99720 4/20 0.45
HRH1 P35367 3/20 0.44
ABCB1 P08183 1/20 0.43
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
SLC6A2 P23975 2/20 0.42
CHRM2 P08172 1/20 0.42
ADRA2C P18825 1/20 0.42
KCNH2 Q12809 1/20 0.42
CACNA1C Q13936 1/20 0.42
SCN5A Q14524 1/20 0.42
DRD2 P14416 1/20 0.42
EBP Q15125 2/20 0.42
TMEM97 Q5BJF2 2/20 0.42
CHRM4 P08173 1/20 0.41
HTR2C P28335 1/20 0.41
HTR7 P34969 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904416 0.99 ABCB1 (0.44) HRH3SIGMAR1HRH1ABCB1SLC6A4
SCHEMBL19904510 0.95 ABCB1 (0.43) HRH3SIGMAR1HRH1ABCB1SLC6A4
SCHEMBL19904585 0.88 SIGMAR1 (0.40) HRH3SIGMAR1HRH1ABCB1SLC6A4
SCHEMBL7999028 0.85 L3MBTL1 (0.51) HRH3SIGMAR1HRH1SLC6A4SLC6A3
SCHEMBL24045454 0.84 HRH1 (0.47) HRH3SIGMAR1HRH1ABCB1SLC6A4
SCHEMBL19043653 0.83 SIGMAR1 (0.55) HRH3SIGMAR1ABCB1EBPTMEM97
SCHEMBL16695116 0.82 CSNK2A1 (0.52) HRH3SIGMAR1HRH1SLC6A4SLC6A3
SCHEMBL16595882 0.81 SLC6A4 (0.51) HRH3SIGMAR1HRH1ABCB1SLC6A4
SCHEMBL21122862 0.81 ABCB1 (0.46) HRH3SIGMAR1HRH1ABCB1SLC6A4
SCHEMBL16595899 0.81 CSNK2A1 (0.53) HRH3SIGMAR1HRH1SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed